• FDA Aproved for Nail Fungus

    September 28, 2011 – Light Age Inc., a Somerset, NJ based private developer and manufacturer of laser products, has received US FDA marketing approval for its Q-Clear™ laser systems for the treatment of onychomycosis. Onychomycosis, more commonly known as nail fungal infection, is caused by common dermatophytes, such as Trichophyton rubrum, that infect the nail bed and matrix.

    FDA Aproved for Nail Fungus
  • Q-Switched, Dual Wavelength

    Q-Clear™ is a revolution in size, simplicity, and price – all while providing the performance expected only from much more costly, but less versatile, large-box systems. Q-Clear™’s elegant design, variable spot sizes and pulse energies, and its dual output wavelengths permit effective, consistent treatment of 17 FDA approved indications. For many procedures good efficacy demands high fluence, ample spot size, and precise control.

Q-Clear™, the first high performance, portable, and truly affordable Dual Wavelength Q-Switched Nd:YAG Laser System (1064 nm & 532 nm) for treating onychomycosis, tattoos, pigmented lesions, vascular lesions, leg & facial veins, skin resurfacing and other dermatological conditions.

the affordably priced Q-Clear™ is compact and user friendly. Having all the power and performance of its large-box competitors, the Q-Clear™ Q-switched Nd:YAG laser weighs less than 35 lbs and its compact ergonomic hand-piece weighs only about 1 lb. Backed by a three year limited warranty and FDA cleared for more than a dozen indications, the Q-Clear™ is an ideal first laser and is a welcome complement to an established practice. For many procedures good efficacy demands high fluence, ample spot size, and precise control. The Q-Clear™'s advanced laser physics, and efficient, state-of-the-art design provides this and more. It provides the speed, comfort, and value your practice and your sanity require. –Light Age Inc.